Evidence map›Paper›PMID 38781074›Full record

ArticleCell reports2024

Protective role for kidney TREM2

Ayshwarya Subramanian, Katherine A Vernon, Yiming Zhou, Jamie L Marshall, Maria Alimova, Carlos Arevalo, Fan Zhang, Michal Slyper, Julia Waldman, Monica S Montesinos and 26 more

Abstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. A population-scale atlas of blood and tissue in lupus nephritis.bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. TREM2-driven peripheral macrophage regulation in inflammatory diseases: implications extending beyond neurological disorders.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. RasGRP4 Exacerbates Diabetic Kidney Fibrosis via Aloxe3-Mediated Oxidative Stress and Scar-Associated Macrophage Activation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  19. TREM2Experimental physiology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Ayshwarya SubramanianKlarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: as3894@cornell.edu.
Katherine A VernonBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Yiming ZhouBroad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: zhouym35@mail.sysu.edu.cn.
Jamie L MarshallBroad Institute of MIT and Harvard, Cambridge, MA, USA; Kidney Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Maria AlimovaKidney Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Carlos ArevaloBroad Institute of MIT and Harvard, Cambridge, MA, USA; Kidney Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Fan ZhangDepartment of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Michal SlyperKlarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Julia WaldmanKlarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Monica S MontesinosBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Danielle DionneBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Lan T NguyenBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Michael S CuocoBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Dan DubinskyKlarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Jason PurnellKlarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Keith KellerKidney Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Samuel H SturnerBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Elizabeth GrinkevichKidney Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Ayan GhoshalBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Amanda KotekDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Giorgio TrivioliMolecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK; Nephrology Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Nathan RichozMolecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
Mary B HumphreyDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Isabella G DarbyDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Sarah J MillerDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Yingping XuInstitute of Dermatology and Venereology, Dermatology Hospital, Southern Medical University, Guangzhou, China.
Astrid WeinsDepartment of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Alexandra Chloe-VillaniBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Steven L ChangCenter for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA.
Matthias KretzlerInternal Medicine, Department of Nephrology, University of Michigan, Ann Arbor, MI, USA.
Orit Rosenblatt-RosenKlarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Jillian L ShawBroad Institute of MIT and Harvard, Cambridge, MA, USA; Kidney Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Kurt A ZimmermanDepartment of Internal Medicine, Division of Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Menna R ClatworthyMolecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK; Cellular Genetics, Wellcome Sanger Institute, Hinxton, UK; NIHR Cambridge Biomedical Research Center, Cambridge, UK; Cambridge Institute of Therapeutic Immunology and Infectious Diseases, Cambridge, UK.
Aviv RegevKlarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Anna GrekaBroad Institute of MIT and Harvard, Cambridge, MA, USA; Kidney Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: agreka@broadinstitute.org.

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Molecular mechanisms of podocyte injury in FSGSR01DK095045 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Anna Greka, Juan Lorenzo Pablo · 2014 to 2026
$5.1M
Role of TRPC5 channel inhibition in the treatment of glomerular diseaseR01DK099465 · NIDDK · BROAD INSTITUTE, INC. · PI Anna Greka · 2014 to 2026
$5.1M
Opera Phenix high-throughput microplate confocal imager for high-content screeningS10OD026839 · OD · BROAD INSTITUTE, INC. · PI WAGNER, BRIDGET K · 2019 to 2019
$1.0M
NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK095045NIDDK NIH HHS R01 DK099465NIH HHS S10 OD026839
6 · The paper itself

Abstract

Diabetic kidney disease (DKD), the most common cause of kidney failure, is a frequent complication of diabetes and obesity, and yet to date, treatments to halt its progression are lacking. We analyze kidney single-cell transcriptomic profiles from DKD patients and two DKD mouse models at multiple time points along disease progression-high-fat diet (HFD)-fed mice aged to 90-100 weeks and BTBR ob/ob mice (a genetic model)-and report an expanding population of macrophages with high expression of triggering receptor expressed on myeloid cells 2 (TREM2) in HFD-fed mice. TREM2

Indexed as

Diabetic NephropathiesDiet, High-FatKidneyMacrophagesMembrane GlycoproteinsMice, KnockoutObesityReceptors, ImmunologicAnimalsFemaleHumansMaleMiceMice, Inbred C57BLMembrane GlycoproteinsReceptors, ImmunologicTREM2 protein, humanTrem2 protein, mouseCP: Immunologydiabetic kidney diseaseimmuneinflammationmacrophagemyeloidsingle-cell transcriptomicsTREM2

Identifiers

PMID38781074
PMCPMC11249042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.